Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Chorev

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Advances in Experimental Medicine and Biology|April 30, 2009
Side chain-to-side chain cyclization by intramolecular click reaction--building blocks, solid phase synthesis and conformational characterizationSonia Cantel, Jose A Halperin, Michael Chorev, et al.
Cancer Research|January 22, 2011
Human CD59 inhibitor sensitizes rituximab-resistant lymphoma cells to complement-mediated cytolysisWeiguo Hu, Xiaowen Ge, Tao You, et al.
Nature Chemical Biology|July 19, 2011
Chemical genetics identify eIF2α kinase heme-regulated inhibitor as an anticancer targetTing Chen, Duygu Ozel, Yuan Qiao, et al.
Journal of Medicinal Chemistry|October 28, 2014
1,4-disubstituted-[1,2,3]triazolyl-containing analogues of MT-II: design, synthesis, conformational analysis, and biological activityChiara Testa, Mario Scrima, Manuela Grimaldi, et al.
Current Pharmaceutical Design|May 31, 2012
Removal of the tag from His-tagged ILYd4, a human CD59 inhibitor, significantly improves its physical properties and its activityLin Wu, Sanbao Su, Fengming Liu, et al.
The Journal of Organic Chemistry|May 21, 2008
Synthesis and conformational analysis of a cyclic peptide obtained via i to i+4 intramolecular side-chain to side-chain azide-alkyne 1,3-dipolar cycloadditionSonia Cantel, Alexandra Le Chevalier Isaad, Mario Scrima, et al.
Pathogens (Basel, Switzerland)|February 23, 2024
Activity of the Di-Substituted Urea-Derived Compound I-17 in <i>Leishmania</i> In Vitro InfectionsJosé Vitorino Dos Santos, Jorge Mansur Medina, Karina Luiza Dias Teixeira, et al.
Cell|January 27, 2007
Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4GNathan J Moerke, Huseyin Aktas, Han Chen, et al.
Diabetes Care|April 29, 2017
Plasma Glycated CD59, a Novel Biomarker for Detection of Pregnancy-Induced Glucose IntolerancePamela Ghosh, Miguel A Luque-Fernandez, Anand Vaidya, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 22, 2023
Design, synthesis, conformational analysis, and biological activity of Cα<sup>1</sup>-to-Cα<sup>6</sup> 1,4- and 4,1-disubstituted 1<i>H</i>-[1,2,3]triazol-1-yl-bridged oxytocin analoguesFrancesca Nuti, Maud Larregola, Agnieszka Staśkiewicz, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Advances in Experimental Medicine and Biology|April 30, 2009
Side chain-to-side chain cyclization by intramolecular click reaction--building blocks, solid phase synthesis and conformational characterizationSonia Cantel, Jose A Halperin, Michael Chorev, et al.
Cancer Research|January 22, 2011
Human CD59 inhibitor sensitizes rituximab-resistant lymphoma cells to complement-mediated cytolysisWeiguo Hu, Xiaowen Ge, Tao You, et al.
Nature Chemical Biology|July 19, 2011
Chemical genetics identify eIF2α kinase heme-regulated inhibitor as an anticancer targetTing Chen, Duygu Ozel, Yuan Qiao, et al.
Journal of Medicinal Chemistry|October 28, 2014
1,4-disubstituted-[1,2,3]triazolyl-containing analogues of MT-II: design, synthesis, conformational analysis, and biological activityChiara Testa, Mario Scrima, Manuela Grimaldi, et al.
Current Pharmaceutical Design|May 31, 2012
Removal of the tag from His-tagged ILYd4, a human CD59 inhibitor, significantly improves its physical properties and its activityLin Wu, Sanbao Su, Fengming Liu, et al.
The Journal of Organic Chemistry|May 21, 2008
Synthesis and conformational analysis of a cyclic peptide obtained via i to i+4 intramolecular side-chain to side-chain azide-alkyne 1,3-dipolar cycloadditionSonia Cantel, Alexandra Le Chevalier Isaad, Mario Scrima, et al.
Pathogens (Basel, Switzerland)|February 23, 2024
Activity of the Di-Substituted Urea-Derived Compound I-17 in <i>Leishmania</i> In Vitro InfectionsJosé Vitorino Dos Santos, Jorge Mansur Medina, Karina Luiza Dias Teixeira, et al.
Cell|January 27, 2007
Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4GNathan J Moerke, Huseyin Aktas, Han Chen, et al.
Diabetes Care|April 29, 2017
Plasma Glycated CD59, a Novel Biomarker for Detection of Pregnancy-Induced Glucose IntolerancePamela Ghosh, Miguel A Luque-Fernandez, Anand Vaidya, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|September 22, 2023
Design, synthesis, conformational analysis, and biological activity of Cα<sup>1</sup>-to-Cα<sup>6</sup> 1,4- and 4,1-disubstituted 1<i>H</i>-[1,2,3]triazol-1-yl-bridged oxytocin analoguesFrancesca Nuti, Maud Larregola, Agnieszka Staśkiewicz, et al.
Pageof 6